Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin pumps--still a research tool?

T Lauritzen, S Pramming

    Annals of Clinical Research
    |January 1, 1984
    PubMed
    Summary

    Portable insulin pumps offer near-normal blood glucose control but are costly. Strict metabolic control via continuous subcutaneous insulin infusion may not prevent retinopathy, necessitating further research on pump therapy benefits and risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Early-onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-Results from the DD2 study.

    Diabetes/metabolism research and reviews·2017
    Same author

    Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes.

    Diabetes/metabolism research and reviews·2016
    Same author

    Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus.

    Diabetic medicine : a journal of the British Diabetic Association·2016
    Same author

    Short-term telemedical home blood pressure monitoring does not improve blood pressure in uncomplicated hypertensive patients.

    Journal of human hypertension·2016
    Same author

    Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial.

    Diabetic medicine : a journal of the British Diabetic Association·2015
    Same author

    The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study.

    Diabetic medicine : a journal of the British Diabetic Association·2015

    Area of Science:

    • Endocrinology
    • Metabolic Diseases
    • Diabetes Management

    Background:

    • Continuous subcutaneous insulin infusion (CSII) via portable insulin pumps offers potential for long-term near-normal blood glucose regulation.
    • Patient acceptance of insulin pump therapy is generally high, despite its significant cost.
    • Understanding pharmacokinetic differences between CSII and conventional injection therapy is crucial for interpreting blood glucose control outcomes.

    Purpose of the Study:

    • To evaluate the effectiveness of near-normal blood glucose regulation achieved with insulin pumps in preventing diabetic microvascular complications, specifically retinopathy.
    • To discuss the pharmacokinetic differences between CSII and conventional insulin injection therapy.
    • To identify the current indications and limitations for routine insulin pump use.

    Main Methods:

    • Comparative analysis of pharmacokinetic profiles between continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    • Review of clinical outcomes regarding blood glucose control and microvascular complication development (retinopathy) in patients using insulin pumps.
    • Assessment of patient acceptability and cost-effectiveness of insulin pump therapy.

    Main Results:

    • One year of near-normal blood glucose control with insulin pumps did not prevent the progression of proliferative retinopathy in patients with pre-existing diabetic background retinopathy.
    • Significant pharmacokinetic differences exist between CSII and conventional injections, influencing blood glucose regulation.
    • The side effects of insulin pump treatment require further clarification before widespread adoption.

    Conclusions:

    • Long-term, large-scale prospective trials are essential to determine if strict metabolic control can impact microvascular complications.
    • Current indications for insulin pump therapy are limited to cases of considerable glycemic instability that impair quality of life.
    • Further research is needed to fully elucidate the benefits, risks, and long-term efficacy of continuous subcutaneous insulin infusion.

    Related Experiment Videos